Development of Machine Learning Platforms that Accelerate Drug Discovery and Molecular Screening for Cancers, Autoimmune Diseases, And Neurological Disorders. AJEMA. 2025;3(12):8-18. Accessed January 27, 2026. https://grnjournal.us.e-scholar.org/index.php/AJEMA/article/view/8731